Abstract
BackgroundTreatment outcomes remain poor in recurrent platinum-resistant ovarian cancer. Enadenotucirev, a tumor-selective and blood stable adenoviral vector, has demonstrated a manageable safety profile in phase 1 studies in epithelial solid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have